MedTrace Logo

Clinical Outcomes of Surgery After Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

NCT05888129 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2023-06-05

No results posted yet for this study

Summary

The purpose of this study was to investigate the clinical outcomes of patients with locally advanced pancreatic cancer (LA-PC) who underwent surgery after neoadjuvant chemotherapy (NACT) at Asan Medical Center's Department of Hepato-Biliary-Pancreatic Surgery from 2017 to 2020.

Conditions

  • Postoperative Complications

Interventions

PROCEDURE

surgery after neoadjuvant chemotherapy

surgery after neoadjuvant chemotherapy

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Song Cheol Kim, MD. PhD · Asan Medical Center

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2020-12-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05888129 on ClinicalTrials.gov